Accenture Reports Higher Revenue, Operating Income, and Diluted EPS on Both Quarter and Half-Year Windows in Interim Filing

Bottom line

- Accenture plc reported higher Revenues for both the three-month reporting period and the six-month year-to-date period compared with the prior-year comparative windows, with Revenues for the six-month year-to-date period of $36,786,191,000 USD against the prior-year comparative of $34,348,846,000 USD, and Revenues for the three-month reporting period of $18,044,066,000 USD against the prior-year comparative of $16,659,301,000 USD. - Operating Income (Loss) moved higher year over year on both windows, with Operating Income (Loss) for the six-month year-to-date period of $5,367,245,000 USD versus $5,193,191,000 USD, and Operating Income (Loss) for the three-month reporting period of $2,493,547,000 USD versus $2,244,714,000 USD. - Net Income (Loss) Attributable to Parent for the six-month year-to-date period of $4,036,800,000 USD was lower than the prior-year comparative of $4,066,969,000 USD, while Net Income (Loss) Attributable to Parent for the three-month reporting period of $1,825,239,000 USD was higher than the prior-year comparative of $1,788,075,000 USD, with both periods remaining profitable. - Earnings Per Share, Diluted for the six-month year-to-date period of $6.47 per diluted share USD/SHARES was higher than the prior-year comparative of $6.42 per diluted share USD/SHARES, and Earnings Per Share, Diluted for the three-month reporting period of $2.93 per diluted share USD/SHARES was higher than the prior-year comparative of $2.82 per diluted share USD/SHARES.

REPORTING-PERIOD IDENTITY AND SOURCE SCOPE: - This analysis covers Accenture plc, trading under ACN, in its interim filing identified by 10-Q for fiscal period period-ended-2026-02-28, filed under accession 0001467373-26-000014 with CIK 0001467373. - The reporting windows addressed are the three-month reporting period of the three months ended February 28, 2026 compared with the prior-year comparative of the three months ended February 28, 2025, and the six-month year-to-date period of the six months ended February 28, 2026 compared with the prior-year comparative of the six months ended February 28, 2025. - Source scope is the unaudited interim Consolidated Financial Statements and accompanying notes in Part I of 10-Q, including the Consolidated Income Statement, the Consolidated Shareholders' Equity Statement for the Three Months Ended February (omitted) and for the Six Months Ended February (omitted), and the Basis of Presentation and accounting-policies disclosures. - The Balance Sheet, Statement of Cash Flows, segment note disclosures, and the remaining Items in Part II (including Item 1 through Item 6) are not the focus of this section; segment-level Revenue and Operating Income detail referenced through Note 12 is not separately broken out in the headline numbers cited above.

- The headline Revenue and Operating Income expansion aligns across both windows, while Net Income diverged between the year-to-date window (lower) and the quarter (higher); the absence of tax, share-count, or one-time-disclosure detail within this section's filing evidence prevents linking these patterns to a single cause. The filing evidence does not attribute this change to any single cause.

COUNTER-EVIDENCE OR MISSING LINES: - The filing evidence does not include the prior-period Net Income relationship in the reported list for the three-month reporting period in a form this section can assert beyond the authorized direction, so the reader is referred to the cited FACT keys above for the exact figures. - No external peer or industry comparison data is available within the filing evidence. The filing evidence contains no peer or industry comparison. - Segment-level disaggregation for the dimensions above is not disclosed in the headline statements cited. The filing evidence does not disclose segment-level detail for this dimension.

UNKNOWN: - Any cause for the year-to-date Net Income decline, any segment-level attribution of Revenue or Operating Income, and any peer benchmark for Accenture plc in this interim period are not stated within the filing evidence and are flagged through the machine-owned NOTE lines above rather than narrated as guesses.

Financial performance

- For the three-month reporting period, Revenues were $18,044,066,000 USD, compared with $16,659,301,000 USD in the prior-year comparative for the three-month reporting period, an authorized increase from a positive prior reading. - For the six-month year-to-date period, Revenues were $36,786,191,000 USD, compared with $34,348,846,000 USD in the prior-year comparative for the six-month year-to-date period, also an authorized increase from a positive prior reading. - Operating Income (Loss) for the three-month reporting period was $2,493,547,000 USD, compared with $2,244,714,000 USD in the prior-year comparative for the three-month reporting period, an authorized increase from a profit to a profit reading.

- Operating Income (Loss) for the six-month year-to-date period was $5,367,245,000 USD, compared with $5,193,191,000 USD in the prior-year comparative for the six-month year-to-date period, an authorized increase on a profit-to-profit basis. - Net Income (Loss) Attributable to Parent for the three-month reporting period was $1,825,239,000 USD, compared with $1,788,075,000 USD in the prior-year comparative for the three-month reporting period, an authorized increase from a profit to a profit reading. - For the six-month year-to-date period, Net Income (Loss) Attributable to Parent was $4,036,800,000 USD, compared with $4,066,969,000 USD in the prior-year comparative for the six-month year-to-date period; this comparison is an authorized decrease from a profit to a profit reading.

82 per diluted share USD/SHARES in the prior-year comparative for the three-month reporting period, an authorized increase on a profit-to-profit basis. 42 per diluted share USD/SHARES in the prior-year comparative for the six-month year-to-date period, also an authorized increase on a profit-to-profit basis. S.

GAAP and reflect all adjustments of a normal, recurring nature that management considers necessary for a fair presentation of interim results. - Management cautions that estimates used in preparing those statements may differ from actual results, and that the results of operations for the three and six months ended February of the reporting year are not necessarily indicative of results for the full fiscal year. - The filing does not present a quantitative or qualitative forward outlook for the next quarter or the full fiscal year; no revenue range, EPS guidance or margin target is disclosed in the cited evidence, so any forecast would be outside what the document states.

- Several pending accounting standards are discussed, including updates to income tax disclosures, disaggregation of income statement expenses and targeted improvements to internal-use-software capitalization, each of which management is still evaluating for timing and disclosure impact. - The cited segment reporting note is referenced for the disaggregation of revenues, and contract-estimate adjustments in prior periods were described as immaterial. - The filing evidence does not attribute this change to any single cause.

- The filing evidence contains no peer or industry comparison.

Operating drivers and segments

The consolidated income statement for the three-month reporting period the three months ended February 28, 2026 shows Revenues of $18,044,066,000 and Operating Income of $2,493,547,000, compared with Revenues of $16,659,301,000 and Operating Income of $2,244,714,000 for the three months ended February 28, 2025. The six-month year-to-date window the six months ended February 28, 2026 records Revenues of $36,786,191,000 against Operating Income of $5,367,245,000, with the corresponding prior-year six-month figures of $34,348,846,000 in Revenues and $5,193,191,000 in Operating Income for the six months ended February 28, 2025. The filing evidence contains no peer or industry comparison. The filing cross-refers readers to the cited note titled Segment Reporting, identified as Note 12, for the disaggregation of Revenues by industry group, type of work and geographic region, but the quoted source narrative in this section does not restate those segment totals, so individual segment contribution margins cannot be independently verified from the material provided here. Management attributes the period-over-period movement in operating profitability to ordinary-course factors such as headcount-related cost absorption, project mix and the timing of transition amortization, while signalling that any change in the allowance for credit losses on client receivables and contract assets is driven primarily by changes in specific client reserves, gross client receivables and contract assets and immaterial write-offs. The interim disclosure under the cited segment note is positioned as the authoritative basis for understanding the composition of revenue, and management cautions that interim results for the three months ended February 28, 2026 and the six months ended February 28, 2026 are not necessarily indicative of the full fiscal year that ends in August. The filing evidence does not attribute this change to any single cause. The filing evidence contains no management commentary that attributes the revenue or operating-income trajectory to a single identifiable driver, and no language in the quoted text attributes the segment outcome to pricing actions, volume shifts, currency moves or acquisition contribution. The unaudited interim Consolidated Financial Statements are described by management as prepared in accordance with U.S. GAAP, with adjustments limited to those of a normal, recurring nature that are considered necessary for a fair presentation of the interim periods, and readers are directed to the Annual Report on Form filed with the SEC for the prior fiscal year for context that is not repeated here.

Independent analysis is constrained because the quoted filing excerpt surfaces only the consolidated totals and a limited set of footnotes, and it does not reproduce the segment disaggregation that the cited note is meant to provide. As a result, the contrast between management's qualitative commentary and an independent reading of segment-level economics cannot be developed further without leaning on the segment note itself, which sits outside the quoted material in this section. The filing evidence does not attribute this change to any single cause. Investors who wish to test management's framing against the underlying composition of revenue and operating income should therefore consult the segment disclosure referenced in the filing rather than rely solely on the consolidated figures shown here.

Cash flow and capital

The balance sheet at the reporting date showed cash and cash equivalents of $9,399,183,000 on the asset side, alongside accounts receivable (net of allowance for credit loss) of $13,761,417,000 and accounts payable of $3,116,735,000. Management does not break out, in the cited disclosures, how those working-capital balances compare with the prior fiscal year-end, so any narrative on receivables or payables turning into a cash tailwind or drag this half is unsupported by the filing evidence.

On the cash flow statement, operating activities generated $5,481,735,000 for the six-month year-to-date period, an authorized increase over the prior-year comparative of $3,875,886,000 reported under 10-Q period-ended-2026-02-28 for Accenture plc. Investing activities used -$2,245,752,000, heavier than the prior-year comparative outflow of -$792,808,000. Financing activities moved from a source of $546,720,000 in the prior year to a use of -$5,324,415,000, an authorized directional decrease that left financing as a net consumer of cash rather than a provider. The filing evidence does not attribute these shifts to any single cause, and the filing narrative on revenue recognition, transition costs and contract assets is silent on what specifically tipped financing below the line.

Within those three flows, capital expenditures (payments to acquire property, plant, and equipment) of $306,267,000 were lower than the prior-year comparative of $323,017,000, an authorized decrease, even as the broader investing outflow widened — a pattern consistent with larger non-capex investing items absorbing cash rather than PP&E build, though the cited disclosures do not confirm which line items drove the gap. Share repurchases, captured within financing, totalled $4,009,652,000, an authorized increase from $2,346,082,000, reinforcing that buybacks remained the principal return-of-capital lever even as the financing line as a whole flipped to a net use.

Counter-evidence worth flagging: the filing notes that the majority of client contracts are terminable on short notice, that only the non-cancelable portion feeds remaining performance obligations, and that adjustments in contract estimates related to performance obligations satisfied or partially satisfied in prior periods were immaterial for the six months ended February (omitted). That language cuts both ways — it supports predictable near-term cash conversion while capping the visibility of the contracted backlog behind that conversion. The filing also discloses redeemable noncontrolling interests tied to put/call options on acquired entities, which sit above equity on the balance sheet and can require cash settlement, but no redemption activity is quantified in the cited disclosures.

Unknowns for this section include the composition of the larger investing outflow beyond PP&E, the drivers behind the swing in financing cash, and any segment-level capital allocation detail beyond what is referenced through the segment reporting note. The filing evidence does not attribute this change to any single cause. Readers comparing this interim with peer interim filings can cross-check working-capital cadence using a window such as Costco Wholesale Posts Higher Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and the Eight-Month Year-to-Date Windows, though the filing evidence contains no peer or industry comparison specific to this filing.

Peer and historical context

The current 10-Q filed by Accenture plc under accession 0001467373-26-000014 for period-ended-2026-02-28 gives a six-month year-to-date and a three-month view against the prior-year windows, so the strongest historical comparison a reader can draw here is internal year-over-year rather than cross-company. The revenue line moved higher in both windows: $36,786,191,000 versus $34,348,846,000 for the the six months ended February 28, 2026 versus the six months ended February 28, 2025 comparison, and $18,044,066,000 versus $16,659,301,000 for the the three months ended February 28, 2026 versus the three months ended February 28, 2025 comparison, with the authorized direction being an increase in each case.

Operating income followed the same pattern, with $5,367,245,000 higher than $5,193,191,000 and $2,493,547,000 higher than $2,244,714,000, both profit-to-profit transitions, while earnings per share, on a diluted basis, also moved higher on both the half-year and the quarter views. The contrast sits on the bottom line: net income attributable to parent was lower for the six months ended February 28, 2026 than for the six months ended February 28, 2025, a profit-to-profit move that runs opposite to the revenue and operating-income trajectory, while for the three months ended February 28, 2026 it was higher than the three months ended February 28, 2025, again profit to profit.

Cash generation moved the other way, with net cash from operating activities higher for the six months ended February 28, 2026 than for the six months ended February 28, 2025. Against that backdrop, a reader can place this filing alongside other interim filings that show similar year-over-year lift in revenue, operating income, net income and diluted EPS, such as TE Connectivity Reports Higher Revenue, Operating Income, Net Income, and Diluted EPS Year-Over-Year in Interim Filing and ONEOK Posts Higher Revenue, Operating Income, Net Income and Diluted EPS Year-Over-Year in Interim Filing, which frame the same directional pattern across unrelated industries.

The filing evidence contains no peer or industry comparison. Because the filing evidence here contains no industry benchmarks, peer margins, or consensus estimates, any read-across to Accenture plc's consulting and managed-services peers would be the reader's own judgement rather than something grounded in this filing, and The filing evidence does not attribute this change to any single cause. The filing evidence does not attribute this change to any single cause.

The half-year net-income softness despite higher revenue and higher operating income is the most striking historical anomaly, and within this section the only honest stance is to flag it without inventing a driver.

Scenario analysis

The base case for Accenture plc under the 10-Q for period-ended-2026-02-28 is a continuation of the revenue and earnings trajectory already printed on the face of the filing. Revenues for the three-month reporting period were $18,044,066,000 USD, higher than the prior-year comparative of $16,659,301,000 USD, and revenues for the six-month year-to-date window were $36,786,191,000 USD, higher than the prior-year comparative of $34,348,846,000 USD. Net Income (Loss) Attributable to Parent for the quarter was $1,825,239,000 USD, higher than the prior-year comparative of $1,788,075,000 USD; on the six-month window net income was $4,036,800,000 USD, lower than the prior-year comparative of $4,066,969,000 USD. The base path is the operating margin that produced those reported figures, alongside the EPS trajectory authorised for the diluted earnings per share line, which moved higher on both the quarter and the half-year windows with a profit-to-profit transition in each case.

The upside scenario assumes that contract momentum captured in the remaining performance obligations disclosure translates into recognised revenue at a pace consistent with the year-to-date revenue growth of $36,786,191,000 USD over $34,348,846,000 USD. Under that path, the Note 12 segment mix would keep supporting higher revenues of $18,044,066,000 USD versus $16,659,301,000 USD, and the higher quarter net income of $1,825,239,000 USD versus $1,788,075,000 USD would extend into the second half rather than reverting. Operating income, which the authorised comparison records as higher on both the quarter and half-year windows with a profit-to-profit transition, would compound the upside through the same channel that is already visible in the diluted EPS authorised direction.

The downside scenario assumes that the six-month net income of $4,036,800,000 USD versus the higher prior-year $4,066,969,000 USD is the start of a softer half-year cadence, even while the three-month quarter net income of $1,825,239,000 USD versus $1,788,075,000 USD still screens as higher. Under that path, contract estimate adjustments, which the filing describes as immaterial for the three and six months ended February (omitted) and (omitted), could move away from immaterial and compress operating margins in a later window. The filing evidence does not attribute this change to any single cause.

Counter-evidence to the downside is the higher three-month revenue of $18,044,066,000 USD versus $16,659,301,000 USD and the higher six-month revenue of $36,786,191,000 USD versus $34,348,846,000 USD, both consistent with the upside path; counter-evidence to the upside is the lower six-month net income of $4,036,800,000 USD versus $4,066,969,000 USD. The filing evidence contains no peer or industry comparison.

Risks and what to watch

- Reported facts: For the three-month reporting period, Revenues were $18,044,066,000 USD and Net Income (Loss) Attributable to Parent was $1,825,239,000 USD, compared with the prior-year three-month window where Revenues were $16,659,301,000 USD and Net Income was $1,788,075,000 USD. For the six-month year-to-date period, Revenues were $36,786,191,000 USD and Net Income (Loss) Attributable to Parent was $4,036,800,000 USD, against the prior-year year-to-date Revenues of $34,348,846,000 USD and Net Income of $4,066,969,000 USD.

Filing identity is 10-Q period-ended-2026-02-28 filed by Accenture plc under accession 0001467373-26-000014 and ticker ACN. - Management explanation: Management frames contract activity around remaining performance obligations and contract assets, noting that a significant portion of what they consider contract bookings is not included in remaining performance obligations, that contract-estimate adjustments related to previously satisfied performance obligations were immaterial for the three and six months ended February (omitted), and that deferred transition costs are monitored for impairment when projected undiscounted operating cash flows fall short of carrying amounts.

Receivables and Contract assets, net of allowance, are presented alongside Contract liabilities (Deferred revenues) as of February (omitted) and August (omitted). - Analyst inference: Both the top line and bottom line contracted at the half-year level while expanding at the quarter level, a mixed pattern that may reflect timing of bookings conversion rather than a steady trend, and the disconnect between revenue direction and net-income direction across the two windows is itself a watch-item. - Counter-evidence: Contract-estimate adjustments were characterized as immaterial for both the three- and six-month windows, and changes in contract asset and liability balances during the six months ended February (omitted) were attributed to normal business activity rather than unusual factors, which tempers downside concerns on contract quality.

The dilutive share treatment excludes only an immaterial amount of restricted stock units. - Unknowns: Segment-level performance under the disaggregation discussed in the cited note is not laid out here. The filing also contains no peer or industry comparison, so relative positioning against other large consulting and outsourcing peers is not addressed.

Management does not attribute the half-year net-income decline to any single cause. The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison.

The filing evidence does not disclose segment-level detail for this dimension. - Metrics to watch next period: the sequential path of Revenues and Net Income relative to the prior-year base, the balance of Receivables and Contract assets versus Deferred revenues at the next reporting date, any sign of contract-estimate adjustments moving beyond immaterial, deferred-transition-cost impairment signals, and operating cash flow versus investing and financing flows as outlined under Item 3. Readers comparing quarter and half-year moves across issuers can cross-check similar patterns in Costco Wholesale Posts Higher Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and the Eight-Month Year-to-Date Windows for context.